Glenmark Pharmaceuticals Inc., USA
Drug manufacturer · manufacturer
Unclaimed listing
340
Drug products
11
Therapeutic areas
About
Glenmark Pharmaceuticals Inc., USA is listed in the FDA National Drug Code Directory with 340 marketed products, of which 340 are prescription drugs. Dosage forms include TABLET, KIT, CAPSULE, CREAM, INSERT. Portfolio includes DEA-scheduled controlled substances.
What Glenmark Pharmaceuticals Inc., USA makes
340 productsOther · 155Cardiovascular · 56Immunology & Inflammation · 42Anti-infective · 29Injectable & Infusion · 17Hormones & Endocrine · 12CNS & Psychiatry · 6Nutrition & Supplements · 6Pain & Anesthesia · 6Dermatology · 6
tablet · 171capsule · 56injection · 46kit · 20ointment · 13cream · 11gel · 8aerosol · 4suspension · 2lotion · 2
- abiraterone acetateabiraterone acetatetabletoralANDA
- abiraterone acetateabiraterone acetatetabletoralANDA
- Acamprosate Calciumacamprosate calciumtablet, delayed releaseoralANDA
- Acetylcysteineacetylcysteineinjection, solutionintravenousANDA
- acycloviracyclovirointmenttopicalANDA
- adapalene and benzoyl peroxideadapalene and benzoyl peroxidegeltopicalANDA
- Alclometasone Dipropionatealclometasone dipropionateointmenttopicalANDA
- Amlodipine and Olmesartan Medoxomilamlodipine and olmesartan medoxomiltablet, film coatedoralANDA
- Amlodipine and Olmesartan Medoxomilamlodipine and olmesartan medoxomiltablet, film coatedoralANDA
- Amlodipine and Olmesartan Medoxomilamlodipine and olmesartan medoxomiltablet, film coatedoralANDA
- Amlodipine and Olmesartan Medoxomilamlodipine and olmesartan medoxomiltablet, film coatedoralANDA
- AprepitantaprepitantcapsuleoralANDA
- AprepitantaprepitantcapsuleoralANDA
- AprepitantaprepitantkitANDA
- AprepitantaprepitantcapsuleoralANDA
- ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLEasprin and extended-release dipyridamolecapsuleoralANDA
- atomoxetineatomoxetinecapsuleoralANDA
- atomoxetineatomoxetinecapsuleoralANDA
- atomoxetineatomoxetinecapsuleoralANDA
- atomoxetineatomoxetinecapsuleoralANDA
- atomoxetineatomoxetinecapsuleoralANDA
- atomoxetineatomoxetinecapsuleoralANDA
- atomoxetineatomoxetinecapsuleoralANDA
- atovaquoneatovaquonesuspensionoralANDA
Page 1 of 15Next ›
Contact
Email and website are not published in the public registries — they are added when the listing is claimed.
From the FDA NDC Directory, refreshed 2026-08-15.
Is this your business?
Claim the listing to publish your catalog, answer buyer enquiries and bid on sourcing requests.
Claim this listing